{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:29:44Z","timestamp":1778754584826,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,14]]},"DOI":"10.7759\/cureus.108829","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:55:32Z","timestamp":1778752532000},"source":"Crossref","is-referenced-by-count":0,"title":["Giant Uterine Leiomyoma With Concomitant Occult Ovarian Carcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Stefanos","family":"Flindris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effrosyni","family":"Styliara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Galaziou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Tsirkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Dinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minas","family":"Paschopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iordanis","family":"Navrozoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-02959-3","article-title":"Massive uterine fibroid: a diagnostic dilemma: a case report and review of the literature","volume":"15","author":"Viva W","year":"2021","unstructured":"Viva W, Juhi D, Kristin A, Micaela M, Marcus B, Ibrahim A, Dirk B. Massive uterine fibroid: a diagnostic dilemma: a case report and review of the literature. J Med Case Rep. 2021, 15:344. 10.1186\/s13256-021-02959-3","journal-title":"J Med Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3764","article-title":"Giant uterine leiomyoma with surgical difficulty","volume":"12","author":"Mongan S","year":"2021","unstructured":"Mongan S, Wibowo A. Giant uterine leiomyoma with surgical difficulty. J Med Cases. 2021, 12:386-90. 10.14740\/jmc3764","journal-title":"J Med Cases"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart EA","year":"2017","unstructured":"Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017, 124:1501-12. 10.1111\/1471-0528.14640","journal-title":"BJOG"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-224052","article-title":"Management of a giant uterine leiomyoma","volume":"2018","author":"Lim PT","year":"2018","unstructured":"Lim PT, Tan CH, Chia HL, Phoon J. Management of a giant uterine leiomyoma. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-224052","journal-title":"BMJ Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78764","article-title":"A rare case of giant uterine leiomyomata: a difficult diagnosis accompanied by surgical difficulties","volume":"17","author":"Thanasa E","year":"2025","unstructured":"Thanasa E, Thanasa A, Xydias EM, et al.. A rare case of giant uterine leiomyomata: a difficult diagnosis accompanied by surgical difficulties. Cureus. 2025, 17:e78764. 10.7759\/cureus.78764","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29020056","article-title":"Outcomes of enhanced recovery after surgery (ERAS) in gynecologic oncology: a review","volume":"29","author":"Bisch SP","year":"2022","unstructured":"Bisch SP, Nelson G. Outcomes of enhanced recovery after surgery (ERAS) in gynecologic oncology: a review. Curr Oncol. 2022, 29:631-40. 10.3390\/curroncol29020056","journal-title":"Curr Oncol"},{"key":"ref7","article-title":"A giant fibroid uterus","volume":"54","author":"Evans AT 3rd","year":"1979","unstructured":"Evans AT 3rd, Pratt JH. A giant fibroid uterus. Obstet Gynecol. 1979, 54:385-6.","journal-title":"Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X211063137","article-title":"Delayed presentation of giant uterine fibroids in a Nigerian private specialist health facility","volume":"9","author":"Ikechebelu JI","year":"2021","unstructured":"Ikechebelu JI, Okpala BC, Eleje GU, Nwachukwu CE, Nwajiaku LA, Nnoruka M. Delayed presentation of giant uterine fibroids in a Nigerian private specialist health facility. SAGE Open Med Case Rep. 2021, 9:2050313X211063137. 10.1177\/2050313X211063137","journal-title":"SAGE Open Med Case Rep"},{"key":"ref9","article-title":"Giant uterine tumors: case report and review of the literature","volume":"50","author":"Jonas HS","year":"1977","unstructured":"Jonas HS, Masterson BJ. Giant uterine tumors: case report and review of the literature. Obstet Gynecol. 1977, 50:2s-4s.","journal-title":"Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66017","article-title":"Challenging surgical management of giant uterine leiomyomas with ileal resection: a clinical case study","volume":"16","author":"Yadav P","year":"2024","unstructured":"Yadav P, Agrawal M, Chaudhari K, Sindhu A. Challenging surgical management of giant uterine leiomyomas with ileal resection: a clinical case study. Cureus. 2024, 16:e66017. 10.7759\/cureus.66017","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80101","article-title":"Giant uterine tumor compatible with sarcoma","volume":"17","author":"Gallardo-Navarro E","year":"2025","unstructured":"Gallardo-Navarro E, Saad Ganem A, Acosta Blanco AM, Muradas Gil L, Garcia Rodriguez FM. Giant uterine tumor compatible with sarcoma. Cureus. 2025, 17:e80101. 10.7759\/cureus.80101","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2016.08.240","article-title":"A new model to preoperatively exclude the risk of sarcoma in patients affected by uterine mass: the uterine mass Magna Graecia (U.M.G.) risk-score","volume":"23","author":"Di CA","year":"2016","unstructured":"Di CA, Venturella R, Marra ML, et al.. A new model to preoperatively exclude the risk of sarcoma in patients affected by uterine mass: the uterine mass Magna Graecia (U.M.G.) risk-score. J Minim Invasive Gynecol. 2016, 23:S98. 10.1016\/j.jmig.2016.08.240","journal-title":"J Minim Invasive Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.07.020","article-title":"Specificity of the lactate dehydrogenase isoenzyme index as a preoperative screen for uterine sarcoma before myomectomy","volume":"115","author":"Spivack LE","year":"2021","unstructured":"Spivack LE, Glantz JC, Lennon C, Bhagavath B. Specificity of the lactate dehydrogenase isoenzyme index as a preoperative screen for uterine sarcoma before myomectomy. Fertil Steril. 2021, 115:174-9. 10.1016\/j.fertnstert.2020.07.020","journal-title":"Fertil Steril"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.05.005","article-title":"High negative prediction for the Basel sarcoma score: sonographic assessment of features suspicious of uterine sarcoma","volume":"174","author":"Knipprath-M\u00e9sz\u00e1ros AM","year":"2023","unstructured":"Knipprath-M\u00e9sz\u00e1ros AM, Tozzi A, Butensch\u00f6n A, et al.. High negative prediction for the Basel sarcoma score: sonographic assessment of features suspicious of uterine sarcoma. Gynecol Oncol. 2023, 174:182-9. 10.1016\/j.ygyno.2023.05.005","journal-title":"Gynecol Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2024-005823","article-title":"ESGO\/EURACAN\/GCIG guidelines for the management of patients with uterine sarcomas","volume":"34","author":"Ray-Coquard I","year":"2024","unstructured":"Ray-Coquard I, Casali PG, Croce S, et al.. ESGO\/EURACAN\/GCIG guidelines for the management of patients with uterine sarcomas. Int J Gynecol Cancer. 2024, 34:1499-521. 10.1136\/ijgc-2024-005823","journal-title":"Int J Gynecol Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004355","article-title":"Prospective evaluation of an enhanced recovery after surgery (ERAS) pathway in a Norwegian cohort of patients with suspected or advanced ovarian cancer","volume":"33","author":"Lindemann K","year":"2023","unstructured":"Lindemann K, Kleppe A, Eyj\u00f3lfsd\u00f3ttir B, et al.. Prospective evaluation of an enhanced recovery after surgery (ERAS) pathway in a Norwegian cohort of patients with suspected or advanced ovarian cancer. Int J Gynecol Cancer. 2023, 33:1279-86. 10.1136\/ijgc-2023-004355","journal-title":"Int J Gynecol Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-019-02359-7","article-title":"Uterine artery embolisation for women with giant versus non-giant uterine fibroids: a systematic review and meta-analysis","volume":"43","author":"Llewellyn O","year":"2020","unstructured":"Llewellyn O, Patel NR, Mallon D, Quinn SD, Hamady M. Uterine artery embolisation for women with giant versus non-giant uterine fibroids: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2020, 43:684-93. 10.1007\/s00270-019-02359-7","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"29","author":"Colombo N","year":"2019","unstructured":"Colombo N, Sessa C, Bois AD, et al.. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer. 2019, 29:728-60. 10.1136\/ijgc-2019-000308","journal-title":"Int J Gynecol Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31825c7cbe","article-title":"Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?","volume":"22","author":"Mizuno M","year":"2012","unstructured":"Mizuno M, Kajiyama H, Shibata K, et al.. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?. Int J Gynecol Cancer. 2012, 22:1143-9. 10.1097\/IGC.0b013e31825c7cbe","journal-title":"Int J Gynecol Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2017.07.005","article-title":"Laparoscopic versus open hysterectomy for benign disease in uteri weighing >1\u2009kg: a retrospective analysis on 258 patients","volume":"25","author":"Uccella S","year":"2018","unstructured":"Uccella S, Morosi C, Marconi N, et al.. Laparoscopic versus open hysterectomy for benign disease in uteri weighing >1\u2009kg: a retrospective analysis on 258 patients. J Minim Invasive Gynecol. 2018, 25:62-9. 10.1016\/j.jmig.2017.07.005","journal-title":"J Minim Invasive Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/475734-giant-uterine-leiomyoma-with-concomitant-occult-ovarian-carcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:55:35Z","timestamp":1778752535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/475734-giant-uterine-leiomyoma-with-concomitant-occult-ovarian-carcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.108829","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}